Nefiracetam
| Nefiracetam | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 246.30 g/mol [1] |
| Predicted LogP | 1.4 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C14H18N2O2 |
| IUPAC name | N-(2,6-dimethylphenyl)-2-(2-oxopyrrolidin-1-yl)acetamide |
| SMILES | CC1=C(C(=CC=C1)C)NC(=O)CN2CCCC2=O |
| InChI | InChI=1S/C14H18N2O2/c1-10-5-3-6-11(2)14(10)15-12(17)9-16-8-4-7-13(16)18/h3,5-6H,4,7-9H2,1-2H3,(H,15,17) |
| InChIKey | NGHTXZCKLWZPGK-UHFFFAOYSA-N |
| CAS number | 77191-36-7 |
| UNII | 1JK12GX30N |
| PubChem CID | 71157 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 3-5 hours[3] |
| Routes of administration | Oral |
Nefiracetam (also known as Nefiracetamum, Dm-9384, 1-Pyrrolidineacetamide, N-(2,6-dimethylphenyl)-2-oxo-, N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide, N-(2,6-Dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl]acetamide, Dm 9384, Motiva, Translon, 2-Oxo-1-pyrrolidineaceto-2',6'-xylidide or Dm9384;dzl-221) is a substance of the aniline and racetam class.
Chemistry
Stereochemistry []
Nefiracetam is achiral.
Druglikeness
Lipinski's rule of five
Nefiracetam matches Lipinski's rule of five.Pharmacology
MeSH Classification
- central nervous system agents (M0003803)
- psychotropic drugs (M0018063)
- neuroprotective agents (M0028008)
- nootropic agents (M0028009)
Legal status []
- Australia: Nefiracetam is a Schedule 4.
- United States: Nefiracetam is Unscheduled.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 71157, Nefiracetam. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/71157
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Nefiracetam. UNII: 1JK12GX30N. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/1JK12GX30N
Fujimaki Y, Sudo K, Hakusui H, Tachizawa H, Murasaki M. Single- and multiple-dose pharmacokinetics of nefiracetam, a new nootropic agent, in healthy volunteers. The Journal of Pharmacy and Pharmacology. September 1992; 44(9):750–754. PMID 1360528. https://doi.org/10.1111/j.2042-7158.1992.tb05513.x
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 08:01:06 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 08:01:02 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 08:01:02 |
| gsrs | ok | 2026-11-20 08:01:02 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0255503) | 2026-11-20 08:01:02 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 08:01:05 |
| pubchem | ok | 2026-11-20 08:01:02 |
| missing (no r/tripreports posts mention it) | 2026-11-20 08:01:02 | |
| sider | missing (not in SIDER) | 2026-11-20 08:01:02 |
| structure | ok | 2026-11-20 08:01:02 |
| wikipedia | ok | 2026-11-20 08:01:02 |